The risk of yo-yo effects, where patients lose muscle on the drug and regain fat after stopping, is a real concern
Researchers should not conflate the reputation, legal status, or product quality of one company with the other based solely on name similarity
You know, anytime you lose weight, you feel better
Overall, the study supports the real-world effectiveness of oral semaglutide for glycemic control, body weight reduction, lipid markers, and ALT improvement in adults with T2D who met Finnish reimbursement criteria, while highlighting the need for further controlled research on longer-term persistence and liver-related outcomes
Thats 26 years of looking at whats out there and being honest about what works
Talk to your prescribing physician about this specific concern